Cengild Medical Berhad (KLSE:CENGILD)
Malaysia · Delayed Price · Currency is MYR 0.2050
-0.0100 (-4.65%)
At close: Jun 5, 2026
Cengild Medical Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 73.15 | 80 | 66.82 | 70.28 | 64.44 | 63.47 | |
Revenue Growth (YoY) | -4.54% | 19.72% | -4.92% | 9.06% | 1.53% | 62.00% |
Cost of Revenue | 39.21 | 43.12 | 35.75 | 39.55 | 38.39 | 36.79 |
Gross Profit | 33.94 | 36.87 | 31.07 | 30.73 | 26.05 | 26.68 |
Selling, General & Admin | 23.27 | 22.05 | 17.86 | 16.24 | 14.48 | 12.21 |
Other Operating Expenses | 0.83 | - | - | - | - | - |
Operating Expenses | 24.59 | 22.54 | 17.86 | 16.26 | 14.48 | 12.21 |
Operating Income | 9.35 | 14.33 | 13.21 | 14.46 | 11.57 | 14.47 |
Interest Expense | -0.28 | -0.39 | -0.6 | -0.73 | -0.85 | -1.22 |
Earnings From Equity Investments | 0.91 | 0.47 | -0.35 | - | - | -0 |
Other Non Operating Income (Expenses) | 3.56 | 3.59 | 4.48 | 3.65 | 1.39 | 0.22 |
EBT Excluding Unusual Items | 13.54 | 18.01 | 16.73 | 17.37 | 12.11 | 13.47 |
Pretax Income | 13.54 | 18.01 | 16.73 | 17.37 | 12.11 | 13.47 |
Income Tax Expense | 3.29 | 4.44 | 4.77 | 4.09 | 2.72 | 3.46 |
Earnings From Continuing Operations | 10.25 | 13.57 | 11.97 | 13.29 | 9.39 | 10 |
Earnings From Discontinued Operations | -0.84 | -2.51 | -0.89 | - | - | - |
Net Income | 9.41 | 11.06 | 11.08 | 13.29 | 9.39 | 10 |
Net Income to Common | 9.41 | 11.06 | 11.08 | 13.29 | 9.39 | 10 |
Net Income Growth | -9.22% | -0.19% | -16.64% | 41.50% | -6.13% | 153.15% |
Shares Outstanding (Basic) | 833 | 833 | 833 | 819 | 644 | 600 |
Shares Outstanding (Diluted) | 833 | 833 | 834 | 826 | 645 | 600 |
Shares Change (YoY) | -0.02% | -0.11% | 1.00% | 27.94% | 7.56% | 4700.00% |
EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 |
EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 |
EPS Growth | -9.06% | -0.19% | -17.39% | 10.46% | -12.59% | -94.73% |
Free Cash Flow | -62.46 | -21.18 | -2.8 | 11.78 | 14.9 | 12.6 |
Free Cash Flow Per Share | -0.07 | -0.03 | -0.00 | 0.01 | 0.02 | 0.02 |
Dividend Per Share | 0.007 | 0.010 | 0.007 | 0.007 | 0.004 | - |
Dividend Growth | -27.83% | 31.08% | - | 100.00% | - | - |
Gross Margin | 46.40% | 46.10% | 46.50% | 43.72% | 40.42% | 42.03% |
Operating Margin | 12.78% | 17.91% | 19.77% | 20.58% | 17.95% | 22.79% |
Profit Margin | 12.86% | 13.82% | 16.58% | 18.91% | 14.57% | 15.76% |
Free Cash Flow Margin | -85.39% | -26.48% | -4.19% | 16.77% | 23.12% | 19.85% |
EBITDA | 14.29 | 19.39 | 15.76 | 16.33 | 14.56 | 17.56 |
EBITDA Margin | 19.53% | 24.23% | 23.58% | 23.23% | 22.60% | 27.67% |
D&A For EBITDA | 4.93 | 5.06 | 2.55 | 1.87 | 2.99 | 3.1 |
EBIT | 9.35 | 14.33 | 13.21 | 14.46 | 11.57 | 14.47 |
EBIT Margin | 12.78% | 17.91% | 19.77% | 20.58% | 17.95% | 22.79% |
Effective Tax Rate | 24.32% | 24.65% | 28.48% | 23.52% | 22.48% | 25.72% |